GT Metabolic Solutions’ use of a 50mm magnet in the MagDI System has received clearance from the US Food and Drug Administration (FDA), supporting the technology’s applicability in magnet-assisted surgeries for duodenal-ileal anastomosis.
Anastomosis is the surgical connection of two structures.
The MagDI System is a self-aligning, incisionless, sutureless and staple-free technology designed to facilitate this procedure.
Created by GT Metabolic Solutions co-founder and chief medical officer Michel Gagner, the MagDI System now offers surgeons the flexibility to choose a 40mm or the larger 50mm magnet, allowing for a tailored approach to patient care
GT Metabolic Solutions is focused on advancing surgical technologies that enhance patient outcomes.
It is expediting the market release of the MagDI System in the US by partnering with hospital centres and surgeons.
Related: Ronovo Surgical wins regulatory nod for laparoscopic surgical robot in China
The system’s efforts are supported by clinical evidence that underscores the efficacy of its sutureless and staple-free approach, with no leaks or bleeds reported.
GT Metabolic Solutions CEO and co-founder Thierry Thaure stated: “This expansion reinforces our commitment to pushing the boundaries of minimally invasive, magnetic surgery and providing surgeons with more advanced tools to improve patient outcomes.”
MagDI System’s incisionless, self-aligning, staple-free design does not leave behind foreign material which would hinder the tissue’s natural healing process.
Gagner stated: “We are eager to bring this transformative approach to even more surgeons and patients.
“The clinical success we’ve seen so far reinforces the role of magnetic compression for anastomosis in bariatric surgery today, and bringing the option of a larger 50mm magnet allows us to broaden the impact of the MagDI System.”
The company’s offerings also include the development of delayed anastomosis technology (DAT). This magnetic compression solution is engineered to provide stable anastomosis while aiming to reduce potential complications like bleeding and leaking.
